Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

Hagiwara, S ; Kudo, M ; Nagai, T ; Inoue, T ; Ueshima, K ; Nishida, N ; Watanabe, T ; Sakurai, T

British journal of cancer, 2012-06, Vol.106 (12), p.1997-2003 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível